SCHEDULE 13G/A: Sabby Entities Disclose Passive 0.7% Stake in Tonix Pharmaceuticals
Beneficial Ownership Report
Sabby Management, Sabby Volatility Warrant Master Fund, and Hal Mintz have jointly disclosed a passive beneficial ownership of 0.7% of Tonix Pharmaceuticals Holding Corp.'s common stock as of December 31, 2024.
Summary
- Sabby Management, LLC, Sabby Volatility Warrant Master Fund Ltd, and Hal Mintz have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Tonix Pharmaceuticals Holding Corp.
- As of December 31, 2024, the reporting persons collectively beneficially own 1,306,313 shares of Tonix Pharmaceuticals' Common Stock.
- This ownership represents 0.7% of the total outstanding class of securities.
- The filing indicates that the shares are held with shared voting power and shared dispositive power among the reporting persons.
- The filing is made under Rule 13d-1(d), signifying a passive investment where the securities were not acquired or held for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that inherently conveys positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of passive beneficial ownership by an investment entity and individual, common in the financial industry. It does not provide specific insights into Tonix Pharmaceuticals' operational or strategic direction, nor does it directly relate to broader industry trends beyond the general activity of institutional investment in public companies.
Stakeholder Impact
- Shareholders: Provides transparency regarding a passive ownership stake by Sabby entities, confirming their current holding percentage.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (beneficial ownership position). |
| 01/03/2025 | Signature date for Sabby Management, LLC, Sabby Volatility Warrant Master Fund LTD, and Hal Mintz. |
Keywords
Tonix Pharmaceuticals, Sabby Management, Sabby Volatility Warrant Master Fund, Hal Mintz, Schedule 13G, Beneficial Ownership, Common Stock, Passive Investment, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.